Anatara Lifesciences (ASX:ANR) Stock Price Down 8%

Anatara Lifesciences Ltd (ASX:ANR) shares dropped 8% during mid-day trading on Tuesday . The company traded as low as A$0.23 ($0.16) and last traded at A$0.23 ($0.16), approximately 21,900 shares changed hands during mid-day trading. The stock had previously closed at A$0.25 ($0.18).

The business has a fifty day simple moving average of A$0.28. The stock has a market cap of $11.37 million and a price-to-earnings ratio of -2.91.

About Anatara Lifesciences (ASX:ANR)

Anatara Lifesciences Limited engages in the development of non-antibiotic oral solutions for gastro intestinal diseases in animals and humans in Australia. Its lead product includes Detach, a non-antibiotic treatment to aid in the control of diarrhoeal diseas. The company is also developing bromelain formulations for gastrointestinal health.

Read More: How can you know how many shares are floating?

Receive News & Ratings for Anatara Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anatara Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.